Oscar Health (NYSE:OSCR) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Oscar Health (NYSE:OSCR - Free Report) from a hold rating to a buy rating in a report released on Saturday morning.

Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $18.50.

Oscar Health Stock Performance

Shares of OSCR stock traded up $0.47 on Friday, hitting $14.27. The company had a trading volume of 12,040,989 shares, compared to its average volume of 4,419,577. The firm has a market cap of $3.63 billion, a P/E ratio of -712.89 and a beta of 1.75. Oscar Health has a twelve month low of $11.20 and a twelve month high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a 50-day moving average price of $13.73 and a 200-day moving average price of $14.59.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion during the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Oscar Health's quarterly revenue was up 42.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.62 EPS. As a group, equities research analysts predict that Oscar Health will post 0.69 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the sale, the director now directly owns 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 24.39% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oscar Health

Large investors have recently made changes to their positions in the stock. Jones Financial Companies Lllp grew its position in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio purchased a new stake in shares of Oscar Health in the first quarter valued at approximately $30,000. Larson Financial Group LLC grew its position in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after purchasing an additional 2,512 shares in the last quarter. CWM LLC grew its position in shares of Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after purchasing an additional 1,078 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its position in shares of Oscar Health by 484.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock valued at $45,000 after purchasing an additional 2,854 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.